MRSA Drugs - Global Strategic Business Report

Global MRSA Drugs Market to Reach $1.6 Billion by 2030

The global market for MRSA Drugs estimated at US$1.1 Billion in the year 2022, is projected to reach a revised size of US$1.6 Billion by 2030, growing at a CAGR of 4.4% over the analysis period 2022-2030. Glycopeptides & Lipoglycopeptides, one of the segments analyzed in the report, is projected to record 4.5% CAGR and reach US$660.2 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Lipopeptides segment is readjusted to a revised 4.9% CAGR for the next 8-year period.

The U.S. Market is Estimated at $339.9 Million, While China is Forecast to Grow at 4.2% CAGR

The MRSA Drugs market in the U.S. is estimated at US$339.9 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$283.5 Million by the year 2030 trailing a CAGR of 4.2% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.1% and 3.7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.

Select Competitors (Total 23 Featured) -

• Absynth Biologics
• Allergan PLC
• AmpliPhi Biosciences Corporation
• AstraZeneca PLC
• Basilea Pharmaceutica Ltd.
• Baxter International, Inc.
• Cempra, Inc.
• CrystalGenomics Inc.
• Debiopharm Group
• Galapagos NV
• GlaxoSmithKline plc
• Innovation Pharmaceuticals Inc.
• Kyorin Pharmaceutical Co., Ltd.
• Lytix Biopharma AS
• Melinta Therapeutics, Inc.
• Merck & Co., Inc.
• Nabriva Therapeutics US, Inc.
• NovaDigm Therapeutics, Inc.
• Paratek Pharmaceuticals, Inc.
• Pfizer, Inc.
• R-Pharm-US LLC
• Savara Inc.
• Sealife PHARMA GMBH
• Sequella, Inc.
• The Medicines Company
• Theravance Biopharma, Inc.
• XBiotech Inc.

What's New?

• Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
• Global competitiveness and key competitor percentage market shares
• Market presence across multiple geographies - Strong/Active/Niche/Trivial
• Online interactive peer-to-peer collaborative bespoke updates
• Access to digital archives and Research Platform
• Complimentary updates for one year